Pre-empting breast cancer: where do we go from here?
Chlebowski
Rowan T
RT
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control*; D004812:Epidemiologic Methods; D005260:Female; D006801:Humans; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D013629:Tamoxifen / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen